Medicine and Dentistry
Observational Study
100%
Biological Marker
64%
Antibiotics
59%
Traumatic Brain Injury
47%
Brain Tissue
47%
Adeno Associated Virus 2
47%
Serositis
43%
Acute Hepatitis
28%
Neonates
23%
Intensive Care
23%
Tracheal Intubation
23%
Protocol Compliance
23%
Emergency Care
23%
Antiinfective Agent
23%
Pedialyte
23%
Informed Consent
23%
Independent Reviewer
23%
Pathogen
23%
Interleukin 6
23%
Enzyme Linked Immunosorbent Assay
23%
Bacterial Pneumonia
23%
Autoantibodies
23%
COVID-19 Vaccination
23%
Patient Referral
23%
Myocarditis
23%
Antibiotic Therapy
19%
Interleukin 10
19%
Partial Least Squares Regression
19%
Clinical Decision Making
16%
Logistic Regression Analysis
15%
Monoclonal Antibody
14%
Closed Head Injury
14%
Rank Sum Test
14%
Glial Cells
14%
Feature Extraction
14%
Human Herpesvirus 6
11%
Human Leukocyte Antigen
11%
Gray Matter
9%
Immunohistochemistry
9%
Liquid Chromatography-Mass Spectrometry
9%
Intubation
8%
Hypoxemia
8%
Extubation
8%
Immunoglobulin G
8%
T Cell
8%
Human Adenovirus C
7%
Disease Predisposition
7%
Effect Size
7%
Immune Deficiency
7%
Clinical Prediction Model
7%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
83%
Traumatic Brain Injury
71%
Antibiotics
59%
Observational Study
52%
Inflammation
43%
Head Injury
28%
Monoclonal Antibody
28%
Antiinfective Agent
23%
Adeno Associated Virus 2
23%
Infectious Agent
23%
Oral Rehydration Solution
23%
Interleukin 6
23%
Enzyme-Linked Immunosorbent Assay
23%
Bacterial Pneumonia
23%
Autoantibodies
23%
Myocarditis
23%
Interleukin 10
19%
Syndrome
16%
Bronchiolitis
11%
Leukocyte Antigen
11%
Axonal Injury
11%
Retrospective Study
11%
Immunoglobulin
11%
Respiratory Virus
11%
Immunoglobulin G
8%
Disease Predisposition
7%
Human Adenovirus C
7%
HIV
7%
Infectious Complication
7%
Acquired Immune Deficiency Syndrome
7%
Immune Deficiency
7%
Oral Rehydration Therapy
6%
Myocardial Disease
6%
Penicillin
6%
Immunoglobulin M
6%
Escherichia coli
5%
Streptococcus Group A
5%
Enterovirus
5%
Influenza B
5%
Influenza A
5%
Immunoglobulin A
5%
Immunology and Microbiology
Adeno Associated Virus 2
47%
Blood Plasma
24%
Infectious Agent
23%
Intracranial Pressure
23%
Glycosylation
23%
Brain Tissue
23%
Interleukin 6
23%
Glycopeptide
23%
Interleukin 10
19%
Human Leukocyte Antigen
11%
Human Herpesvirus 6
11%
Gray Matter
9%
Cell Count
9%
T Cell
8%
Protein Processing
7%
Human Adenovirus C
7%
Protein Expression
7%
Dose Response
7%
Brain Perfusion
5%
Perfusion Pressure
5%
